111 Inc (YI)

111 Stock Price & Analysis


YI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.37 - $6.05
Previous Close$2.71
Average Volume (3M)137.65K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$802.27M
Total Debt (Recent Filing)$96.80M
P/E Ratio-2.5
Next EarningsNov 18, 2022
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-1.06
Shares Outstanding83,271,583
Standard Deviation0.27
10 Day Avg. Volume102,753
30 Day Avg. Volume137,653
P/B Ratio-4.76
P/S Ratio0.16
P/CF RatioN/A
P/FCF Ratio-3.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was 111’s price range in the past 12 months?
111 lowest stock price was $1.37 and its highest was $6.05 in the past 12 months.
    What is 111’s market cap?
    Currently, no data Available
    When is 111’s upcoming earnings report date?
    111’s upcoming earnings report date is Nov 18, 2022 which is in 42 days.
      How were 111’s earnings last quarter?
      111 released its earnings results on Aug 25, 2022. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.16.
        Is 111 overvalued?
        According to Wall Street analysts 111’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does 111 pay dividends?
          111 does not currently pay dividends.
          What is 111’s EPS estimate?
          111’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does 111 have?
          111 has 47,271,584 shares outstanding.
            What happened to 111’s price movement after its last earnings report?
            111 reported an EPS of -$0.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12.917%.
              Which hedge fund is a major shareholder of 111?
              Among the largest hedge funds holding 111’s share is Totem Point Management, LLC. It holds 111’s shares valued at N/A.


                111 Stock Analysis

                Smart ScoreNeutral
                The 111 stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                111 Inc

                111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment engages in the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

                Similar Stocks
                Price & Change
                China Jo-Jo Drugstores
                Aurora Mobile
                Viomi Technology Co
                X Financial
                360 Finance

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis